Replies to post #258331 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

Agree

[BangkokJohnny]

Agree

[Poor Man -]

Agreed. LP is skirting with a revolt if she schedules the ASM without having anything to show.

[rrflyboy]

Your position - "Rank and file shareholders should reject any request for an increase in the number of authorized shares unless reasonable concessions to us like a clear time frame for completion of whatever is pending with the statistical analysis plan, unblinding, and the public release of top line data are given." Absolutely correct! No more vague assurances like "pedal to the metal" which any half-assed lawyer could defend to mean anything they wanted. Put up or get out, or at least LP should donate her time if they are so close to the finish line. Remember the vague pronouncements they made at last year's ASM at how close they were to finishing? Some of the bears prior arguments now appear rational to me given the continual secrecy and failure to produce anything by the Board and management. If it hadn't been for Woodford I would not be invested here. Remember, LP is a fund manager first and she and the compliant, Burisma-like Board indirectly and adroitly used NWBO shareholder money to build up Cognate but then LP was forced by the SEC to disgorge it for conflict of interest reasons. Who got paid? Not the NWBO shareholders. Shareholder money was also used to buy and build up Sawston and then sell off pieces of it to continue to do what again? Now that management and LP have gotten their millions of shares, options and warrants at our expense (read dilution) they appear to be making the moves to sell out and make LP a billionaire and the toast of the town in DC. I would happy at this point to get my original investment returned. Damn that Woodford, and why is Smith now pumping a competitor to NWBO?

[JRIII]

Rank and file shareholders should reject any request for an increase in the number of authorized shares

Too late. Shareholders already agreed to a massive dilution in 2018 that destroyed the value of our holdings by 67 percent. This, in my opinion, was a fatal decision, and it was approved overwhelmingly by shareholders with almost no critical analysis of the implications. Shareholders at the time were convinced that unblinding and topline data were "right around the corner" and that approving the dilution would propel the company "across the finish line."

Here we are two years later and nothing has changed. If the company were to propose another increase in authorized shares shareholders would again approve it overwhelmingly and would still be convinced that unblinding and topline data were right around the corner, pedal to the metal. That's because there are no shareholders quite like NWBO shareholders. They are dumb, and for some reason they think the lying lawyers in charge of this company are going to surprise the world with some announcement that they have a cure for cancer and we are all going to be rich. There was a time long ago when there was reason to believe that might be the case. But not anymore. It should be obvious to everyone what is going on here, and it should have been obvious before that 2018 vote that destroyed our investments. But, alas, there are no shareholders quite like NWBO shareholders.

Company officers used that 2018 vote to provide an extended source of revenue so they could continue enriching themselves. No one can deny two simple facts: 1) Who has gotten rich here? Answer: NWBO officers; and 2) Who has gotten poor here? Answer: NWBO shareholders. With every day that passes, there is less of a chance of that dynamic ever changing, and right now the chances are at zero.